News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
607,942 Results
Type
Article (56251)
Company Profile (103)
Press Release (551588)
Multimedia
Podcasts (53)
Webinars (12)
Section
Business (177543)
Career Advice (1992)
Deals (31414)
Drug Delivery (93)
Drug Development (65871)
Employer Resources (138)
FDA (14907)
Job Trends (12527)
News (295766)
Policy (26589)
Tag
Academia (2693)
Academic (1)
Accelerated approval (6)
Adcomms (11)
Allergies (76)
Alliances (46684)
ALS (83)
Alzheimer's disease (1297)
Antibody-drug conjugate (ADC) (117)
Approvals (14935)
Artificial intelligence (255)
Autoimmune disease (17)
Automation (9)
Bankruptcy (271)
Best Places to Work (9859)
BIOSECURE Act (18)
Biosimilars (107)
Biotechnology (69)
Bladder cancer (66)
Brain cancer (29)
Breast cancer (227)
Cancer (1996)
Cardiovascular disease (153)
Career advice (1647)
Career pathing (33)
CAR-T (139)
Cell therapy (382)
Cervical cancer (19)
Clinical research (52874)
Collaboration (796)
Compensation (241)
Complete response letters (14)
COVID-19 (2250)
CRISPR (36)
C-suite (220)
Cystic fibrosis (90)
Data (1926)
Decentralized trials (2)
Denatured (14)
Depression (43)
Diabetes (244)
Diagnostics (5761)
Digital health (16)
Diversity (4)
Diversity, equity & inclusion (30)
Drug discovery (131)
Drug pricing (91)
Drug shortages (29)
Duchenne muscular dystrophy (81)
Earnings (72568)
Editorial (44)
Employer branding (19)
Employer resources (111)
Events (78841)
Executive appointments (671)
FDA (16045)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (6)
Funding (681)
Gene editing (84)
Generative AI (25)
Gene therapy (282)
GLP-1 (703)
Government (3339)
Grass and pollen (5)
Guidances (60)
Healthcare (15751)
Huntington's disease (16)
IgA nephropathy (23)
Immunology and inflammation (97)
Indications (27)
Infectious disease (2383)
Inflammatory bowel disease (120)
Inflation Reduction Act (6)
Influenza (47)
Intellectual property (85)
Interviews (365)
IPO (14673)
IRA (35)
Job creations (3009)
Job search strategy (1397)
Kidney cancer (8)
Labor market (42)
Layoffs (394)
Leadership (16)
Legal (5775)
Liver cancer (65)
Lung cancer (272)
Lymphoma (131)
Machine learning (6)
Management (40)
Manufacturing (289)
MASH (65)
Medical device (11937)
Medtech (11942)
Mergers & acquisitions (17295)
Metabolic disorders (647)
Multiple sclerosis (71)
NASH (14)
Neurodegenerative disease (81)
Neuropsychiatric disorders (21)
Neuroscience (1777)
NextGen: Class of 2025 (5279)
Non-profit (3982)
Now hiring (39)
Obesity (346)
Opinion (209)
Ovarian cancer (65)
Pain (84)
Pancreatic cancer (72)
Parkinson's disease (127)
Partnered (20)
Patents (210)
Patient recruitment (98)
Peanut (39)
People (49440)
Pharmaceutical (26)
Pharmacy benefit managers (19)
Phase I (15789)
Phase II (22760)
Phase III (18222)
Pipeline (1139)
Policy (124)
Postmarket research (2384)
Preclinical (7812)
Press Release (68)
Prostate cancer (86)
Psychedelics (25)
Radiopharmaceuticals (207)
Rare diseases (333)
Real estate (5327)
Recruiting (54)
Regulatory (19352)
Reports (47)
Research institute (2564)
Resumes & cover letters (314)
Rett syndrome (3)
RNA editing (2)
RSV (43)
Schizophrenia (67)
Series A (110)
Series B (66)
Service/supplier (13)
Sickle cell disease (43)
Special edition (16)
Spinal muscular atrophy (136)
Sponsored (29)
Startups (3085)
State (1)
Stomach cancer (9)
Supply chain (63)
Tariffs (37)
The Weekly (38)
Vaccines (633)
Venture capitalists (31)
Weight loss (249)
Women's health (26)
Worklife (18)
Date
Today (109)
Last 7 days (769)
Last 30 days (2294)
Last 365 days (28244)
2025 (9455)
2024 (30114)
2023 (34436)
2022 (44843)
2021 (48400)
2020 (46498)
2019 (39910)
2018 (30431)
2017 (29583)
2016 (28628)
2015 (34272)
2014 (26816)
2013 (23419)
2012 (24262)
2011 (25055)
2010 (23223)
Location
Africa (743)
Alabama (54)
Alaska (4)
Arizona (154)
Arkansas (11)
Asia (41496)
Australia (7030)
California (4775)
Canada (1703)
China (489)
Colorado (224)
Connecticut (224)
Delaware (109)
Europe (86282)
Florida (795)
Georgia (189)
Idaho (42)
Illinois (435)
India (28)
Indiana (247)
Iowa (9)
Japan (162)
Kansas (87)
Kentucky (12)
Louisiana (11)
Maine (60)
Maryland (720)
Massachusetts (3357)
Michigan (206)
Minnesota (317)
Mississippi (2)
Missouri (79)
Montana (28)
Nebraska (22)
Nevada (52)
New Hampshire (62)
New Jersey (1559)
New Mexico (28)
New York (1501)
North Carolina (851)
North Dakota (7)
Northern California (2050)
Ohio (188)
Oklahoma (10)
Oregon (22)
Pennsylvania (1064)
Puerto Rico (8)
Rhode Island (25)
South America (1064)
South Carolina (23)
Southern California (1839)
Tennessee (88)
Texas (756)
United States (18700)
Utah (148)
Virginia (128)
Washington D.C. (54)
Washington State (488)
West Virginia (3)
Wisconsin (53)
607,942 Results for "persistence market research pvt ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Izotropic Featured in Announcement of Research and Markets’ U.S. Breast Cancer Analysis and Forecast
- Company listed in Research and Markets’ announcement and description of new research report on the U.S. Breast Cancer Screening and Diagnostic Market- - “U.S. breast cancer screening and diagnostic [device] market was valued at $1.55 billion in 2024 and is anticipated to reach $2.34 billion by the end of 2030, at a CAGR of 7.05% during the forecast period 2024-20301"- -Report supports Company’s regulatory strategy for IzoView Breast CT, reinforces high demand for new breast imaging modalities, strengthens the potential for rapid market adoption and significant market share -
January 17, 2025
·
8 min read
Cancer Stem Cells Market to Reach USD 4.5 Billion to 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
According to the latest research by InsightAce Analytic, the Global Cancer Stem Cells Market is valued at US$ 2.1 Bn in 2023, and it is expected to reach US$ 4.5 Bn by 2031, with a CAGR of 9.7% during the forecast period of 2024-2031.
May 17, 2024
·
1 min read
Press Releases
Frontotemporal Dementia Market Size to Reach US$ 688.2 Million by 2035, Impelled by Advancements in Diagnostics and Expanding Research & Development
Frontotemporal Dementia Market Outlook 2025-2035:
February 17, 2025
·
10 min read
Press Releases
Small Cell Lung Cancer Market Size to Reach USD 23.0 Billion by 2035, Impelled by Improved Early Diagnosis & Biomarker Research
Small Cell Lung Cancer Market Outlook 2025-2035:
February 17, 2025
·
9 min read
Press Releases
Resilience Partners with Parvus Therapeutics for Development and Manufacturing of PVT401, a Novel Autoimmune Drug Candidate for IBD
January 8, 2025
·
3 min read
Business
Mid-Atlantic BioTherapeutics, Inc. and SMITM Capital Markets Ltd enter into a significant financing agreement
SMITM CAPITAL MARKETS LTD, has announced a significant agreement with Mid-Atlantic BioTherapeutics, Inc. (MABT), a clinical-stage ready US biopharmaceutical company.
June 19, 2024
·
4 min read
Business
ValGenesis and Life Science Consulting Pvt. Ltd. Form Partnership to Enhance Quality and Compliance for Life Sciences Companies Across North America, Europe, and Asia
ValGenesis, Inc. and Life Science Consulting Pvt. Ltd. have partnered to provide best-in-class digital validation solutions to enhance compliance and quality across life sciences disciplines such as production, quality control and assurance, information technology, and research and development.
May 30, 2023
·
3 min read
Layoffs
Entrada Cuts 20% of Workforce, Targeting Research Employees
Entrada is paring back its research staff even as it gears up to hire employees to support a planned clinical trial for a Duchenne muscular dystrophy candidate.
April 30, 2025
·
1 min read
·
Angela Gabriel
Press Releases
Kairos Pharma Ltd. Provides Letter to Stockholders
April 24, 2025
·
5 min read
BioMidwest
Rafarma pharmaceutical updates: agreements with Shri Lanka pharmaceutical company Kelun Lifesciences (Pvt) Ltd and El Salvador University
Rafarma Pharmaceuticals - We are pleased to announce that Rapharma and its CEO Raivo Unt have entered into a preliminary agreement with Kelun Lifesciences Ltd, a pharmaceutical company based in Sri Lanka, on 17 November 2023.
December 11, 2023
·
3 min read
1 of 60,795
Next
